Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P01275 (
glucagon
)
26,492
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Miniglucagon (MG), the C-terminal
glucagon
fragment, processed from
glucagon
by the MG-generating endopeptidase (MGE) at the Arg17-Arg18 dibasic site, displays biological effects opposite to that of the mother-hormone. This secondary processing occurs in the
glucagon
- and MG-producing alpha-cells of the islets of Langerhans and from circulating
glucagon
. We first characterized the enzymatic activities of MGE in culture media from
glucagon
and MG-secreting alphaTC1.6 cells as made of a metalloendoprotease and an aminopeptidase. We observed that
glucagon
is a substrate for N-arginine dibasic convertase (NRDc), a metalloendoprotease, and that
aminopeptidase B
cleaves in vitro the intermediate cleavage products sequentially, releasing mature MG. Furthermore, immunodepletion of either enzyme resulted in the disappearance of the majority of MGE activity from the culture medium. We found RNAs and proteins corresponding to both enzymes in different cell lines containing a MGE activity (mouse alphaTC1.6 cells, rat hepatic FaO, and rat pituitary GH4C1). Using confocal microscopy, we observed a granular immunostaining of both enzymes in the alphaTC1.6 and native rat alpha-cells from islets of Langerhans. By immunogold electron microscopy, both enzymes were found in the mature secretory granules of alpha-cells, close to their substrate (
glucagon
) and their product (MG). Finally, we found NRDc only in the fractions from perfused pancreas that contain
glucagon
and MG after stimulation by hypoglycemia. We conclude that MGE is composed of NRDc and
aminopeptidase B
acting sequentially, providing a molecular basis for this uncommon regulatory process, which should be now addressed in both physiological and pathophysiological situations.
...
PMID:Miniglucagon (MG)-generating endopeptidase, which processes glucagon into MG, is composed of N-arginine dibasic convertase and aminopeptidase B. 1553 58